Literature DB >> 29759532

Therapeutic Approaches to Atrial Fibrillation Ablation Targeting Atrial Fibrosis.

Hans Kottkamp1, Doreen Schreiber2, Fabian Moser2, Andreas Rieger2.   

Abstract

Atrial fibrosis is the fundamental histopathologic finding in atrial fibrillation (AF) patients and an important predictor of ablation failure beyond pulmonary vein isolation. There is wide variation in the extent and localization of left atrial fibrosis in patients with paroxysmal and nonparoxysmal AF. Box isolation of fibrotic areas is an effective rhythm control concept in patients with paroxysmal AF despite durable pulmonary vein isolation, and this strategy has recently been implemented successfully in initial AF ablation procedures in addition to pulmonary vein isolation for patients with nonparoxysmal AF. In contrast, the time for "empirical" lines or other nonindividualized substrate modifications seems over.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; atrial fibrosis; catheter ablation; fibrotic atrial cardiomyopathy; risk factor; substrate modification

Mesh:

Year:  2017        PMID: 29759532     DOI: 10.1016/j.jacep.2017.05.009

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  8 in total

1.  Predictive value of CTRP3 for the disease recurrence of atrial fibrillation patients after radiofrequency ablation.

Authors:  Zhe Wang; Chao Liang; Yuanfeng Gao; Xianchen Meng; Hongjie Chi; Mulei Chen
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 2.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04

3.  Substrate Targeted Ablation of Atrial Fibrillation Guided by High Density Voltage Mapping: Long-Term Results.

Authors:  Steven J Bailin; Ghanshyam Shantha; Hardik Doshi; Craig Hoffman
Journal:  J Atr Fibrillation       Date:  2020-08-31

4.  Atrial fibrosis underlying atrial fibrillation (Review).

Authors:  Chang Yi Li; Jing Rui Zhang; Wan Ning Hu; Song Nan Li
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

5.  What Is Better Predictor of Late Recurrence after Radiofrequency Catheter Ablation for Atrial Fibrillation?

Authors:  Sung Il Im; Kyoung-Min Park
Journal:  Korean Circ J       Date:  2022-05       Impact factor: 3.101

6.  Bi-atrial characterization of the electrical substrate in patients with atrial fibrillation.

Authors:  Tsitsinakis Giorgios; Frontera Antonio; Luca Rosario Limite; Lipartiti Felicia; David Zweiker; Manuela Cireddu; Kostantinos Vlachos; Alexios Hadjis; Giuseppe D'Angelo; Francesca Baratto; Caterina Bisceglia; Pasquale Vergara; Alessandra Marzi; Giovanni Peretto; Gabriele Paglino; Andrea Radinovic; Simone Gulletta; Simone Sala; Patrizio Mazzone; Paolo Della Bella
Journal:  Pacing Clin Electrophysiol       Date:  2022-04-23       Impact factor: 1.912

7.  Ablation Therapy for Persistent Atrial Fibrillation.

Authors:  Ikechukwu Ifedili; Kristina Mouksian; David Jones; Ibrahim El Masri; Mark Heckle; John Jefferies; Yehoshua C Levine
Journal:  Curr Cardiol Rev       Date:  2022

8.  Toward Patient-Specific Prediction of Ablation Strategies for Atrial Fibrillation Using Deep Learning.

Authors:  Marica Muffoletto; Ahmed Qureshi; Aya Zeidan; Laila Muizniece; Xiao Fu; Jichao Zhao; Aditi Roy; Paul A Bates; Oleg Aslanidi
Journal:  Front Physiol       Date:  2021-05-26       Impact factor: 4.755

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.